Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 979

1.

Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis.

Wu Y, Levis B, Riehm KE, Saadat N, Levis AW, Azar M, Rice DB, Boruff J, Cuijpers P, Gilbody S, Ioannidis JPA, Kloda LA, McMillan D, Patten SB, Shrier I, Ziegelstein RC, Akena DH, Arroll B, Ayalon L, Baradaran HR, Baron M, Bombardier CH, Butterworth P, Carter G, Chagas MH, Chan JCN, Cholera R, Conwell Y, de Man-van Ginkel JM, Fann JR, Fischer FH, Fung D, Gelaye B, Goodyear-Smith F, Greeno CG, Hall BJ, Harrison PA, Härter M, Hegerl U, Hides L, Hobfoll SE, Hudson M, Hyphantis T, Inagaki MD, Jetté N, Khamseh ME, Kiely KM, Kwan Y, Lamers F, Liu SI, Lotrakul M, Loureiro SR, Löwe B, McGuire A, Mohd-Sidik S, Munhoz TN, Muramatsu K, Osório FL, Patel V, Pence BW, Persoons P, Picardi A, Reuter K, Rooney AG, Santos IS, Shaaban J, Sidebottom A, Simning A, Stafford MD, Sung S, Tan PLL, Turner A, van Weert HC, White J, Whooley MA, Winkley K, Yamada M, Benedetti A, Thombs BD.

Psychol Med. 2019 Jul 12:1-13. doi: 10.1017/S0033291719001314. [Epub ahead of print]

PMID:
31298180
2.

A systematic review of the genetic mechanisms of dolutegravir resistance.

Rhee SY, Grant PM, Tzou PL, Barrow G, Harrigan PR, Ioannidis JPA, Shafer RW.

J Antimicrob Chemother. 2019 Jul 5. pii: dkz256. doi: 10.1093/jac/dkz256. [Epub ahead of print]

PMID:
31280314
3.

A limited number of medicines pragmatic trials had potential for waived informed consent following the 2016 CIOMS ethical guidelines.

Dal-Ré R, Avendaño-Solà C, de Boer A, James SK, Rosendaal FR, Stephens R, Ioannidis JPA.

J Clin Epidemiol. 2019 Jun 15;114:60-71. doi: 10.1016/j.jclinepi.2019.06.007. [Epub ahead of print]

PMID:
31212001
4.

A user's guide to inflated and manipulated impact factors.

Ioannidis JPA, Thombs BD.

Eur J Clin Invest. 2019 Jun 17:e13151. doi: 10.1111/eci.13151. [Epub ahead of print] No abstract available.

PMID:
31206647
5.

Solutions to Reduce Unnecessary Imaging-Reply.

Oren O, Kebebew E, Ioannidis JPA.

JAMA. 2019 Jun 11;321(22):2243. doi: 10.1001/jama.2019.4021. No abstract available.

PMID:
31184737
6.

Interventions to improve cardiopulmonary resuscitation: a review of meta-analyses and future agenda.

Chalkias A, Ioannidis JPA.

Crit Care. 2019 Jun 7;23(1):210. doi: 10.1186/s13054-019-2495-5. No abstract available.

7.

Risk and protective factors for anxiety and obsessive-compulsive disorders: an umbrella review of systematic reviews and meta-analyses.

Fullana MA, Tortella-Feliu M, Fernández de la Cruz L, Chamorro J, Pérez-Vigil A, Ioannidis JPA, Solanes A, Guardiola M, Almodóvar C, Miranda-Olivos R, Ramella-Cravaro V, Vilar A, Reichenberg A, Mataix-Cols D, Vieta E, Fusar-Poli P, Fatjó-Vilas M, Radua J.

Psychol Med. 2019 Jun 7:1-16. doi: 10.1017/S0033291719001247. [Epub ahead of print]

PMID:
31172897
8.

Family History-Wide Association Study ("FamWAS") for Identifying Clinical and Environmental Risk Factors for Common Chronic Diseases.

Rasooly D, Ioannidis JPA, Khoury MJ, Patel CJ.

Am J Epidemiol. 2019 Jun 7. pii: kwz125. doi: 10.1093/aje/kwz125. [Epub ahead of print]

PMID:
31172187
9.

Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies.

Ladanie A, Speich B, Briel M, Sclafani F, Bucher HC, Agarwal A, Ioannidis JPA, Pereira TV, Kasenda B, Hemkens LG.

J Clin Epidemiol. 2019 May 31;114:49-59. doi: 10.1016/j.jclinepi.2019.05.033. [Epub ahead of print]

PMID:
31158450
10.

Validation protocols for blood pressure measuring devices: the impact of the European Society of Hypertension International Protocol and the development of a Universal Standard.

O'Brien E, Stergiou G, Palatini P, Asmar R, Ioannidis JP, Kollias A, Lacy P, McManus RJ, Myers MG, Shennan A, Wang J, Parati G; European Society of Hypertension Working Group on Blood Pressure Monitoring.

Blood Press Monit. 2019 Aug;24(4):163-166. doi: 10.1097/MBP.0000000000000391.

PMID:
31116156
11.

Lost Evidence From Registered Large Long-Unpublished Randomized Controlled Trials: A Survey.

Tatsioni A, Karassa FB, Goodman SN, Zarin DA, Fanelli D, Ioannidis JPA.

Ann Intern Med. 2019 May 7. doi: 10.7326/M19-0440. [Epub ahead of print] No abstract available.

PMID:
31060046
12.

Lethal news: The dexterous infiltration of news media by the tobacco industry agenda.

Ioannidis JPA.

Eur J Clin Invest. 2019 Jul;49(7):e13125. doi: 10.1111/eci.13125. Epub 2019 May 18. No abstract available.

PMID:
31058313
13.

Consent insufficient for data release-Response.

Amann RI, Baichoo S, Blencowe BJ, Bork P, Borodovsky M, Brooksbank C, Chain PSG, Colwell RR, Daffonchio DG, Danchin A, de Lorenzo V, Dorrestein PC, Finn RD, Fraser CM, Gilbert JA, Hallam SJ, Hugenholtz P, Ioannidis JPA, Jansson JK, Kim JF, Klenk HP, Klotz MG, Knight R, Konstantinidis KT, Kyrpides NC, Mason CE, McHardy AC, Meyer F, Ouzounis CA, Patrinos AAN, Podar M, Pollard KS, Ravel J, Muñoz AR, Roberts RJ, Rosselló-Móra R, Sansone SA, Schloss PD, Schriml LM, Setubal JC, Sorek R, Stevens RL, Tiedje JM, Turjanski A, Tyson GW, Ussery DW, Weinstock GM, White O, Whitman WB, Xenarios I.

Science. 2019 May 3;364(6439):446. doi: 10.1126/science.aax7509. No abstract available.

PMID:
31048484
14.

Reproducible pharmacokinetics.

Ioannidis JPA.

J Pharmacokinet Pharmacodyn. 2019 Apr;46(2):111-116. doi: 10.1007/s10928-019-09621-y. Epub 2019 Apr 19. Review.

PMID:
31004315
15.

Meta-analyses identify differentially expressed micrornas in Parkinson's disease.

Schulz J, Takousis P, Wohlers I, Itua IOG, Dobricic V, Rücker G, Binder H, Middleton L, Ioannidis JPA, Perneczky R, Bertram L, Lill CM.

Ann Neurol. 2019 Jun;85(6):835-851. doi: 10.1002/ana.25490.

PMID:
30990912
16.

The Importance of Predefined Rules and Prespecified Statistical Analyses: Do Not Abandon Significance.

Ioannidis JPA.

JAMA. 2019 Apr 4. doi: 10.1001/jama.2019.4582. [Epub ahead of print] No abstract available.

PMID:
30946431
17.

Therapy and prevention for mental health: What if mental diseases are mostly not brain disorders?

Ioannidis JPA.

Behav Brain Sci. 2019 Jan;42:e13. doi: 10.1017/S0140525X1800105X.

PMID:
30940221
18.

How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation.

Ioannidis JPA, Kim BYS, Trounson A.

Nat Biomed Eng. 2018 Nov;2(11):797-809. doi: 10.1038/s41551-018-0314-y. Epub 2018 Nov 8.

19.

Bayes factors for superiority, non-inferiority, and equivalence designs.

van Ravenzwaaij D, Monden R, Tendeiro JN, Ioannidis JPA.

BMC Med Res Methodol. 2019 Mar 29;19(1):71. doi: 10.1186/s12874-019-0699-7.

20.

Retiring statistical significance would give bias a free pass.

Ioannidis JPA.

Nature. 2019 Mar;567(7749):461. doi: 10.1038/d41586-019-00969-2. No abstract available.

PMID:
30903096
21.

Signals Among Signals: Prioritizing Nongenetic Associations in Massive Data Sets.

Manrai AK, Ioannidis JPA, Patel CJ.

Am J Epidemiol. 2019 May 1;188(5):846-850. doi: 10.1093/aje/kwz031.

22.

Hypnotic depth and postoperative death: a Bayesian perspective and an Independent Discussion of a clinical trial.

Vlisides PE, Ioannidis JPA, Avidan MS.

Br J Anaesth. 2019 Apr;122(4):421-427. doi: 10.1016/j.bja.2019.01.012. Epub 2019 Feb 22. No abstract available.

23.

Independent discussion sections for improving inferential reproducibility in published research.

Avidan MS, Ioannidis JPA, Mashour GA.

Br J Anaesth. 2019 Apr;122(4):413-420. doi: 10.1016/j.bja.2018.12.010. Epub 2019 Jan 22.

24.

Author Reply to: The name of the game: Is preventive screening "cancer screening?"

Adami HO, Kalager M, Valdimarsdottir U, Bretthauer M, Ioannidis JPA.

Eur J Clin Invest. 2019 Mar 4:e13097. doi: 10.1111/eci.13097. [Epub ahead of print] No abstract available.

PMID:
30829396
25.

Most UK scientists who publish extremely highly-cited papers do not secure funding from major public and charity funders: A descriptive analysis.

Stavropoulou C, Somai M, Ioannidis JPA.

PLoS One. 2019 Feb 27;14(2):e0211460. doi: 10.1371/journal.pone.0211460. eCollection 2019.

26.

Exploration, Inference, and Prediction in Neuroscience and Biomedicine.

Bzdok D, Ioannidis JPA.

Trends Neurosci. 2019 Apr;42(4):251-262. doi: 10.1016/j.tins.2019.02.001. Epub 2019 Feb 23. Review.

PMID:
30808574
27.

Are all mental disorders related to all other medical diseases and vice versa?

Fiedorowicz JG, Ioannidis JPA.

J Psychosom Res. 2019 Mar;118:71-72. doi: 10.1016/j.jpsychores.2019.01.018. Epub 2019 Jan 29. No abstract available.

PMID:
30782358
28.

Hypothesis, analysis and synthesis, it's all Greek to me.

Iliopoulos I, Ananiadou S, Danchin A, Ioannidis JP, Katsikis PD, Ouzounis CA, Promponas VJ.

Elife. 2019 Feb 20;8. pii: e43514. doi: 10.7554/eLife.43514.

29.

Unreformed nutritional epidemiology: a lamp post in the dark forest.

Ioannidis JPA.

Eur J Epidemiol. 2019 Apr;34(4):327-331. doi: 10.1007/s10654-019-00487-5. No abstract available.

PMID:
30746584
30.

PREDIMED trial of Mediterranean diet: retracted, republished, still trusted?

Agarwal A, Ioannidis JPA.

BMJ. 2019 Feb 7;364:l341. doi: 10.1136/bmj.l341. No abstract available.

PMID:
30733217
31.

Environmental risk factors and interventions for obesity.

Solmi M, Ioannidis JPA, Carvalho AF.

Eur J Clin Invest. 2019 May;49(5):e13080. doi: 10.1111/eci.13080. Epub 2019 Feb 25. No abstract available.

PMID:
30725492
32.

Recommendations and Practical Guidance for performing and reporting validation studies according to the Universal Standard for the validation of blood pressure measuring devices by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO).

Stergiou GS, Palatini P, Asmar R, Ioannidis JP, Kollias A, Lacy P, McManus RJ, Myers MG, Parati G, Shennan A, Wang J, O'Brien E; European Society of Hypertension Working Group on Blood Pressure Monitoring.

J Hypertens. 2019 Mar;37(3):459-466. doi: 10.1097/HJH.0000000000002039.

PMID:
30702492
33.

Stealth research: Lack of peer-reviewed evidence from healthcare unicorns.

Cristea IA, Cahan EM, Ioannidis JPA.

Eur J Clin Invest. 2019 Apr;49(4):e13072. doi: 10.1111/eci.13072. Epub 2019 Feb 13. No abstract available.

PMID:
30690709
34.

Toward unrestricted use of public genomic data.

Amann RI, Baichoo S, Blencowe BJ, Bork P, Borodovsky M, Brooksbank C, Chain PSG, Colwell RR, Daffonchio DG, Danchin A, de Lorenzo V, Dorrestein PC, Finn RD, Fraser CM, Gilbert JA, Hallam SJ, Hugenholtz P, Ioannidis JPA, Jansson JK, Kim JF, Klenk HP, Klotz MG, Knight R, Konstantinidis KT, Kyrpides NC, Mason CE, McHardy AC, Meyer F, Ouzounis CA, Patrinos AAN, Podar M, Pollard KS, Ravel J, Muñoz AR, Roberts RJ, Rosselló-Móra R, Sansone SA, Schloss PD, Schriml LM, Setubal JC, Sorek R, Stevens RL, Tiedje JM, Turjanski A, Tyson GW, Ussery DW, Weinstock GM, White O, Whitman WB, Xenarios I.

Science. 2019 Jan 25;363(6425):350-352. doi: 10.1126/science.aaw1280. No abstract available.

35.

Reforming Nutritional Epidemiologic Research-Reply.

Ioannidis JPA.

JAMA. 2019 Jan 22;321(3):310. doi: 10.1001/jama.2018.18676. No abstract available.

PMID:
30667499
36.

Flawed methods and inappropriate conclusions for health policy on overweight and obesity: the Global BMI Mortality Collaboration meta-analysis.

Flegal KM, Ioannidis JPA, Doehner W.

J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):9-13. doi: 10.1002/jcsm.12378. Epub 2019 Jan 17. Review.

37.

Curbing Unnecessary and Wasted Diagnostic Imaging.

Oren O, Kebebew E, Ioannidis JPA.

JAMA. 2019 Jan 22;321(3):245-246. doi: 10.1001/jama.2018.20295. No abstract available.

PMID:
30615023
38.

Limitations and Misinterpretations of E-Values for Sensitivity Analyses of Observational Studies.

Ioannidis JPA, Tan YJ, Blum MR.

Ann Intern Med. 2019 Jan 1. doi: 10.7326/M18-2159. [Epub ahead of print]

PMID:
30597486
39.

New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.

Janiaud P, Serghiou S, Ioannidis JPA.

Cancer Treat Rev. 2019 Feb;73:20-30. doi: 10.1016/j.ctrv.2018.12.003. Epub 2018 Dec 11. Review.

PMID:
30572165
40.

Time to abandon early detection cancer screening.

Adami HO, Kalager M, Valdimarsdottir U, Bretthauer M, Ioannidis JPA.

Eur J Clin Invest. 2019 Mar;49(3):e13062. doi: 10.1111/eci.13062. Epub 2019 Jan 4. No abstract available.

PMID:
30565674
41.

How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure.

Naci H, Salcher-Konrad M, Dias S, Blum MR, Sahoo SA, Nunan D, Ioannidis JPA.

Br J Sports Med. 2019 Jul;53(14):859-869. doi: 10.1136/bjsports-2018-099921. Epub 2018 Dec 18.

PMID:
30563873
42.

Replication, Duplication, and Waste in a Quarter Million Systematic Reviews and Meta-Analyses.

Siontis KC, Ioannidis JPA.

Circ Cardiovasc Qual Outcomes. 2018 Dec;11(12):e005212. doi: 10.1161/CIRCOUTCOMES.118.005212. No abstract available.

PMID:
30562075
43.

A Comprehensive Analysis of Protocols for Deriving Dopaminergic Neurons from Human Pluripotent Stem Cells.

Marton RM, Ioannidis JPA.

Stem Cells Transl Med. 2019 Apr;8(4):366-374. doi: 10.1002/sctm.18-0088. Epub 2018 Dec 10.

44.

Gene-environment interactions and colorectal cancer risk: An umbrella review of systematic reviews and meta-analyses of observational studies.

Yang T, Li X, Montazeri Z, Little J, Farrington SM, Ioannidis JPA, Dunlop MG, Campbell H, Timofeeva M, Theodoratou E.

Int J Cancer. 2018 Dec 11. doi: 10.1002/ijc.32057. [Epub ahead of print] Review.

PMID:
30536881
45.

Cochrane crisis: Secrecy, intolerance and evidence-based values.

Ioannidis JPA.

Eur J Clin Invest. 2019 Mar;49(3):e13058. doi: 10.1111/eci.13058. Epub 2018 Dec 19. No abstract available.

PMID:
30520025
46.

Diagnostic accuracy of the Geriatric Depression Scale-30, Geriatric Depression Scale-15, Geriatric Depression Scale-5 and Geriatric Depression Scale-4 for detecting major depression: protocol for a systematic review and individual participant data meta-analysis.

Benedetti A, Wu Y, Levis B, Wilchesky M, Boruff J, Ioannidis JPA, Patten SB, Cuijpers P, Shrier I, Gilbody S, Ismail Z, McMillan D, Mitchell N, Ziegelstein RC, Thombs BD.

BMJ Open. 2018 Dec 4;8(12):e026598. doi: 10.1136/bmjopen-2018-026598.

47.

Reproducible research practices, transparency, and open access data in the biomedical literature, 2015-2017.

Wallach JD, Boyack KW, Ioannidis JPA.

PLoS Biol. 2018 Nov 20;16(11):e2006930. doi: 10.1371/journal.pbio.2006930. eCollection 2018 Nov.

48.

How often can meta-analyses of individual-level data individualize treatment? A meta-epidemiologic study.

Schuit E, Li AH, Ioannidis JPA.

Int J Epidemiol. 2018 Nov 15. doi: 10.1093/ije/dyy239. [Epub ahead of print]

PMID:
30445577
49.

Marginal structural models and other analyses allow multiple estimates of treatment effects in randomized clinical trials: Meta-epidemiological analysis.

Ewald H, Speich B, Ladanie A, Bucher HC, Ioannidis JPA, Hemkens LG.

J Clin Epidemiol. 2019 Mar;107:12-26. doi: 10.1016/j.jclinepi.2018.11.001. Epub 2018 Nov 10.

PMID:
30423375
50.

The Challenge of Reforming Nutritional Epidemiologic Research.

Ioannidis JPA.

JAMA. 2018 Sep 11;320(10):969-970. doi: 10.1001/jama.2018.11025. No abstract available.

PMID:
30422271

Supplemental Content

Loading ...
Support Center